ACE and chronic kidney disease: However, in the complicated phase, the presence of coronary artery disease, preexisting neurological comorbidities, chronic kidney disease and higher age were independently associated with an increased risk of death, while neither ARB nor ACE inhibitor intake did have an influence on prognosis in multivariate analysis (Fig 2A).